Diagnomics, a leading genetic testing company, has developed a new ACMG 59 report that is available to healthcare providers and…
Shin Shang Cheol
Mr. Shin Shang Cheol is the Chief Operating Officer of the EONE-Diagnomics Genome Center (EDGC) in Korea. He graduated from Yonsei University and has worked for over 20 years at Samsung Securities. His professional experience which he mainly gained from his work at Samsung Securities is very diverse, especially in the wholesale and retail business sector. He was also an executive in Samsung’s Management Support division and his office was located in the Investment Banking Business headquarter.
Mr. Shin’s working experience in Investment Banking involves interaction with hundreds of companies, and his focus is on IPO, M&A, privatization of the public corporation, and capital raises. He has an excellent understanding for issues and solutions which corporations need at various stages of their corporate life cycle.